{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:05:21Z","timestamp":1761609921626},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.semnephrol.2016.09.007","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T17:04:57Z","timestamp":1481735097000},"page":"453-459","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Trials in FSGS: Past Challenges and New Trial Designs"],"prefix":"10.1016","volume":"36","author":[{"given":"Deb","family":"Gipson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2016.09.007_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00467-005-2097-0","article-title":"Differential risk of remission and ESRD in childhood FSGS","volume":"21","author":"Gipson","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1681\/ASN.2004070593","article-title":"Focal and segmental glomerulosclerosis: definition and relevance of a partial remission","volume":"16","author":"Troyanov","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/snep.2003.50021","article-title":"Primum non nocere: should adults with idiopathic FSGS receive steroids?","volume":"23","author":"Franceschini","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib4","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ki.2012.238","article-title":"Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome","volume":"82","author":"Gulati","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/snep.2003.50022","article-title":"Cyclosporine in the treatment of idiopathic focal segmental glomerulosclerosis","volume":"23","author":"Cattran","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib6","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1046\/j.1523-1755.1999.00778.x","article-title":"A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group","volume":"56","author":"Cattran","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1053\/j.ackd.2014.10.001","article-title":"Novel therapies for FSGS: preclinical and clinical studies","volume":"22","author":"Malaga-Dieguez","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.ackd.2014.01.010","article-title":"Treatment of FSGS in children","volume":"21","author":"Sethna","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2215\/CJN.08330812","article-title":"Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS","volume":"8","author":"Hogg","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1681\/ASN.2013111242","article-title":"Clinical features and histology of apolipoprotein L1-associated nephropathy in the FSGS clinical trial","volume":"26","author":"Kopp","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM198901263200403","article-title":"A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy","volume":"320","author":"Cattran","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib12","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s00467-014-2858-8","article-title":"Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study","volume":"29","author":"Selewski","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib13","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00467-015-3074-x","article-title":"The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study","volume":"30","author":"Selewski","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2016.09.007_bib14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2012.428","article-title":"Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach","volume":"83","author":"Gadegbeku","year":"2013","journal-title":"Kidney Int"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516300900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516300900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T01:24:17Z","timestamp":1536197057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929516300900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0270929516300900"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.09.007","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}